Skip to main content
Hiroshi Yamasaki, MD, Cardiology, Roseville, MI

HiroshiYamasakiMD

Cardiology Roseville, MI

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Eastside Cardiovascular Medicine

Dr. Yamasaki is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Yamasaki's full profile

Already have an account?

  • Office

    25195 Kelly Rd
    Ste A
    Roseville, MI 48066
    Phone+1 586-775-4594
    Fax+1 586-775-4506

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Cardiovascular Disease, 1992 - 1995
  • New York-Presbyterian/Queens
    New York-Presbyterian/QueensResidency, Internal Medicine, 1989 - 1992
  • Faculty of Medicine Kyoto University
    Faculty of Medicine Kyoto UniversityClass of 1989

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1996 - 2025
  • PA State Medical License
    PA State Medical License 1992 - 1996
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
  • Fellow (FACP) American College of Physicians, 2003
  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Journal Articles

  • Association of Race with Long-Term Outcomes in Patients Undergoing Popliteal and Infra-Popliteal Percutaneous Peripheral Arterial Interventions  
    Hiroshi Yamasaki, Thomas Lalonde, Rajendra H Mehta, Mohammad Alasaad, Howard S Rosman, ScienceDirect

Press Mentions

  • Dominant-Negative Abrogation of Connexin-Mediated Cell Growth Control by Mutant Connexin Genes
    Dominant-Negative Abrogation of Connexin-Mediated Cell Growth Control by Mutant Connexin GenesOctober 30th, 1997
  • Aberrant Expression, Function and Localization of Connexins in Human Esophageal Carcinoma Cell Lines with Different Degrees of Tumorigenicity
    Aberrant Expression, Function and Localization of Connexins in Human Esophageal Carcinoma Cell Lines with Different Degrees of TumorigenicityAugust 15th, 1994

Professional Memberships